Bio Medica Laboratories Limited (NSE:BMLL)

India · Delayed Price · Currency is INR

177.00

+14.70 (9.06%)

At close: Sep 4, 2026

Market Cap	2.23B
Revenue (ttm)	430.90M +103.0%
Net Income	117.81M +1,900.1%
EPS	12.95 +1,918.4%
Shares Out	12.58M
PE Ratio	13.67
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	67,000
Open	165.00
Previous Close	162.30
Day's Range	165.00 - 181.00
52-Week Range	101.50 - 181.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 27, 2026

About Bio Medica Laboratories

Bio Medica Laboratories Limited engages in manufacturing pharmaceutical parenteral formulations in India. It manufactures variety of products, comprising ethical drugs, generic drugs and over the-counter drugs in the form of injectables namely Liquid Injections and dry powder injections. It provides human injectables, export of injectables, veterinary injectables, contract manufacturing, quality assurance, and research and development services. The company caters to human and veterinary needs. The company was formerly known as Bio Medica Labora... [Read more]

Industry Pharmaceutical Preparations

Founded 1988

Country India

Stock Exchange National Stock Exchange of India

Ticker Symbol BMLL

Full Company Profile

Financial Performance

In fiscal year 2026, Bio Medica Laboratories's revenue was 430.90 million, an increase of 12.81% compared to the previous year's 381.95 million. Earnings were 117.81 million, an increase of 20.27%.

Financial Statements